News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
Biotech/Pharma - Alliances (World)
Galen Signs Exclusive Deal In Europe 9/18/2014
Merck KGaA (MKGAF.PK) Wants Bids For Cancer Therapy Partners 9/18/2014
Boehringer Ingelheim Corporation Will Pay Up To $600 Million For CureVac GmbH Lung Cancer Vaccine 9/18/2014
South San Francisco's Sutro Biopharma Forges $375 Million Antibody Drug Pact With Merck KGaA (MKGAF.PK) 9/17/2014
Bay Area Startup MyoKardia Forges $200 Million Heart Disease Pact With Sanofi (France) (SAN.PA) 9/17/2014
Eli Lilly and Company (LLY) Bets $500 Million On AstraZeneca PLC (AZN)’s Alzheimer's Drug 9/17/2014
Protein Sciences Corporation And Diamyd Medical AB Deepen Commitment To Develop New Treatment For Diabetes 9/17/2014
3SBio Inc. (SSRX) Obtains Exclusive Licenses To Develop And Market Jenkem's PEG-Irinotecan In China 9/17/2014
NuView Life Sciences Inc. Enters Global Licensing Agreement With Otsuka Pharmaceutical Co., Ltd. 9/17/2014
Hetero Enters License Agreement With Gilead Sciences, Inc. (GILD), U.S.A. To Produce Generic Sofosbuvir For Treatment Of Chronic Hepatitis C 9/17/2014
Gilead Sciences, Inc. (GILD) Says Indian Firms May Sell Generics of Hep C Drug Sovaldi 9/16/2014
Lupin Ltd. (LUPN.BO), Merck Serono Forge Emerging Markets Pact; Deal Could Add Up To 20 Drugs To Merck's Portfolio 9/16/2014
PHARNEXT And The Hereditary Neuropathy Foundation Collaborate To Increase Awareness Of Charcot-Marie-Tooth Disease 9/16/2014
Lupin Ltd. (LUPN.BO) May Sign $1.5 Billion Deal With Merck Serono; Lupin Stock Hits A New High 9/15/2014
Evotec AG (EVTG.F) And The Jain Foundation Expand Collaboration: Start Of Multiple Drug Screening Programmes 9/15/2014
Mylan Inc. (MYL) Signs Agreement With Gilead Sciences, Inc. (GILD) To Accelerate Access To Hepatitis C Treatments, Sovaldi® (Sofosbuvir) And Single Tablet Regimen Of Ledipasvir/Sofosbuvir, in Developing Countries 9/15/2014
Cellprothera® And BioCardia Partner On Phase 2 EXCELLENT Trial 9/15/2014
BGI And The Vancouver Prostate Centre Announce Partnership To Create Joint Research Laboratory For Advancement Of Translational Cancer Research 9/12/2014
Evotec AG (EVTG.F) And CHDI, Inc. Foundation Extend Ongoing Collaboration To Fight Huntington's Disease 9/11/2014
Sophia Genetics Announces First Deal With Britain's NHS And Leading Turkish Laboratory, Expanding European Customer Base 9/11/2014
Seattle Genetics, Inc. (SGEN), Genmab A/S (GEN.CO) Partner In $211 Million Antibody-Drug Pact 9/10/2014
Shenzhen Beike Biotechnology Co. Ltd., Altor BioScience Corporation Strike $200 Million Cancer Deal 9/10/2014
Inocucor Technologies Signs First Commercial Strategic Partnership With Axter Agroscience 9/10/2014
Medidata Solutions, Inc. And ICON Join Forces To Bring New Productivity To Capturing Patient Voice In Clinical Trials 9/10/2014
NeuroVive Pharmaceutical AB, Oncore Sign $150 Million Hepatitis B Pact 9/9/2014
Venus Remedies Ties It Up With Mylan Inc. (MYL) For Marketing Meropenem In Three European Countries 9/8/2014
Zhejiang Huahai And Tianjin Pharma To Form U.S.-Aimed Partnership 9/8/2014
University of Toronto Announces Strategic Collaboration With Janssen Inc. And Johnson & Johnson Innovation (JNJ) 9/8/2014
Solentim Ltd Embraces CRISPR And Other Rapid Gene-Editing Technologies With Horizon Discovery Ltd. 9/8/2014
Lee's Pharm In-licenses Second Product From Italy's Abiogen Pharma 9/8/2014
Ophthotech Corporation (OPHT) Banks $50 Million Milestone From Novartis AG (NVS) For Fovista® Pact 9/8/2014
Pfizer Inc. (PFE) Strikes Pact To Market Novartis AG (NVS)'s Respiratory Inhalers In The UK 9/5/2014
Earlier Tumour Diagnosis With Advanced Ultrasound Technology From Oxford University 9/5/2014
Hainan Sinotau In-Licenses Radiopharmaceutical From Navidea Biopharmaceuticals (NAVB) Of The U.S. 9/5/2014
Tiny Redx Pharma Signs "Transformational" Cancer Deal With AstraZeneca PLC (AZN); Financial Terms Have Not Been Disclosed 9/4/2014
Bavarian Nordic (BAVA.CO) Accelerates Ebola Vaccine Development Programs In Collaboration With The National Institutes of Health (NIH) 9/4/2014
Masters Speciality Pharma Enters Agreement With ApoPharma 9/4/2014
Navidea Biopharmaceuticals (NAVB) Enters Lymphoseek® Development And Commercialization Agreement For China 9/4/2014
Vectura Group plc (VEC.L) Release: Announcement Of Commercial Arrangement With Pfizer Inc. (PFE) UK To Promote Ultibro® Breezhaler® And Seebri® Breezhaler® In The United Kingdom 9/4/2014
BeiGene Co.,Ltd Signs China CMO Deal With Boehringer Ingelheim Corporation 9/4/2014
Ablynx (ABLYF) Signs Exclusive License Agreement With Eddingpharm (Cayman) Inc. To Develop And Commercialise Its Anti-Tnfa Nanobody In Greater China 9/2/2014
Amarillo Biosciences (AMAR) Initiates CLIA Development Of Alzheimer's Blood Diagnostic Lympro Test® At ICON Central Laboratories 9/2/2014
Advanced Biological Laboratories SA (ABL) And Mayo Medical Laboratories Announce Collaboration And Licensing Agreements 9/2/2014
CleveXel Pharma Partners With Guilin Pharmaceutical To Develop Two New Anti-Malarial Products 9/2/2014
Amerigen Pharmaceuticals And The Ningbo MENOVO Pharmaceutical Co.,LTD., Today Announced They Had Entered Into A Collaboration Agreement Regarding The Development Of Generic Pharmaceuticals, Primarily Targeting The United States Market 8/27/2014
Bavarian Nordic (BAVA.CO) Receives Order From The Canadian Government To Supply IMVAMUNE® Smallpox Vaccine 8/26/2014
A*STAR, BCA And Hitachi, Ltd. (HIT) Pilot Plant Facilitates Research For Greener Buildings 8/26/2014
Recipharm AB Forms New Collaboration With Isofol Medical AB To Exclusively Manufacture Modufolin® And Invests SEK 8 Million In The Company 8/26/2014
Luye In-Licenses China Rights To Cancer Drug From Korea's Hanmi Pharmaceutical, Co., Ltd 8/22/2014
Antitope And University College London Enter Into A Research & Licence Agreement For The Generation Of Fully Humanized Antibodies Using Antitope’s Composite Human Antibody™ Technology 8/21/2014
DESY And IBM Corporation (IBM) Develop Big Data Architecture For Science 8/21/2014
Illumina, Inc. (ILMN) Partners With AstraZeneca PLC (AZN), Johnson & Johnson (JNJ) To Create New Genetic Tests For Cancer 8/21/2014
AstraZeneca PLC (AZN), Mitsubishi Tanabe Pharma Corporation Link Up For Diabetes Research 8/20/2014
Emergent BioSolutions (EBS), MorphoSys AG Strike Prostate Cancer Pact Worth $183 Million 8/20/2014
Novartis AG (NVS), Global Alliance For TB Drug Development Link Up To Search For TB Cure 8/20/2014
Evotec AG (EVTG.F) And Medicines for Malaria Venture (MMV) Announce A Long-Term Compound Management Collaboration 8/19/2014
A*STAR And Sumitomo Mitsui Banking Corporation Ink MOU To Support Japanese R&D Collaborations With Singapore 8/19/2014
Vectura Group plc (VEC.L) Interim Management Statement 8/19/2014
Amarillo Biosciences (AMAR) Exercises Option To License Intellectual Property From University Of Miami Bascom Palmer Eye Institute For Use Of MANF In Retinal Disorders 8/15/2014
TNI BioTech Expands Partnership With Hubei Qianjiang Pharma 8/14/2014
Roche (RHHBY) Backs Out Of $600 Million Acromegaly Drug Development Deal With Chiasma Inc. 8/14/2014
TNI BioTech And Hubei Qianjiang Pharmaceutical Co., Ltd Supplemental Collaborative Agreement 8/13/2014
RedHill Biopharma Ltd. (RDHL) Acquires Option For Phase 2 Pancreatic Cancer Drug RP101 8/13/2014
Retroscreen Virology Limited Partners With ERT For Centralised ECG Services In Hvivo Challenge Studies 8/13/2014
ProSensa Holding N.V. (RNA) And CureDuchenne Strengthen Long-Term Collaboration With An Additional [Eur]5M To Advance DMD Pipeline 8/12/2014
Myelin Repair Foundation Announces Long-Term European Partnership With Hertie Foundation 8/12/2014
Protein Sciences Corporation And Liomont Announce Licensing Of Proprietary Influenza Vaccines For The Mexico Market 8/12/2014
Sanofi (France) (SAN.PA) To Pay MannKind Corporation (MNKD) Up To $925 Million For Inhaled Insulin 8/12/2014
Novartis AG (NVS), GlaxoSmithKline (GSK) Reshape Pharma With Game-Changing $14.5 Billion Deal 8/12/2014
Amarantus BioSciences, Inc. Enters Into Research Collaboration With The Buck Institute for Age Research For MANF 8/11/2014
Cancer Research Technology And Cancer Research UK Cambridge Research Institute Join Forces With Astellas Pharma Inc. (ALPMY) On Autophagy To Find New Cancer Treatments 8/8/2014
3SBio Inc. (SSRX) Signs Exclusive Patent License Agreement With DinoNa For Leukotuximab 8/8/2014
Eirgenix Signs Agreement With Taimed To Provide Development And Manufacturing Services For Taimed’s Second Generation anti-HIV mAb TMB-360 8/7/2014
Sanofi (France) (SAN.PA), Immune Design Corporation (IMDZ) Strike Food Allergy Deal Worth $168 Million+ 8/7/2014
National Institutes of Health (NIH) And Mesoblast Limited (MSB.AX) Enter Into Agreement for 120-Patient Trial In End-Stage Heart Failure 8/7/2014
Access Pharmaceuticals (ACCP) Announces European License Agreement With Norgine 8/7/2014
Pfizer Inc. (PFE), Roche (RHHBY) Join Consortium In Effort To Up Success Of Late-Phase Clinical Work 8/6/2014
Bavarian Nordic (BAVA.CO) Is The Sole Bidder For Canadian Smallpox Vaccine Supply 8/6/2014
Sanofi (France) (SAN.PA), Emcure Pharmaceuticals Limited Ink Marketing Pact For Cancer Drugs 8/6/2014
OX-MPI Project Returned To Orexo AB (ORXOF) 8/6/2014
Yabao Pharmaceuticals And Changzhou Le Sun Pharmaceuticals Ltd. Enter An Innovative Partnership To Develop Early-Stage Oncology Compound 8/6/2014
AEterna Zentaris (AEZS) And ASCEND Therapeutics, Inc. Sign Co-Promotion Agreement For U.S. Market 8/5/2014
Cesca Therapeutics And Fortis Healthcare Announce Master Collaboration Agreement 8/5/2014
Galapagos NV (GLPG.BR) Receives Milestone In Osteoarthritis Alliance With Servier 8/5/2014
BioGasol Establishes Licensed Carbofrac® Reactor Manufacture By Sweetwater Energy 8/4/2014
Amarantus BioSciences, Inc. Acquires Exclusive Option To License Alzheimer's Therapeutic IP Of Dr. Thomas Arendt From University of Leipzig 8/1/2014
Solasia Pharma K.K. Grabs Global Rights To ZIOPHARM Oncology, Inc. (ZIOP.OB)'s Zinapar For Up To $72.2 Million 8/1/2014
Evotec AG (EVTG.F) Receives First Milestones In TargetAD Collaboration 7/30/2014
AstraZeneca PLC (AZN) Taps Roche (RHHBY) For New Blood-Based Cancer Drug Tests 7/29/2014
Malaria Transmission-blocking Vaccines – ARTES Biotechnology And Burnet Announced A Development Project 7/29/2014
SDK And BIA Separations Expanding Their Co-operation 7/29/2014
Zealand Pharma  (ZEAL.CO), Boehringer Ingelheim Corporation Strike $402 Million Peptide Pact 7/28/2014
AstraZeneca PLC (AZN), QIAGEN N.V. (QGEN) Strike Lung Cancer Diagnostic Pact For Patients Suitable For Treatment With IRESSA 7/28/2014
CN Bio Innovations Marks World Hepatitis Day By Signing Research Agreement With Imperial College London 7/28/2014
Gilead Sciences, Inc. (GILD), Medicines Patent Pool Strike Deal: New Opportunity For Indian Drugmakers 7/24/2014
MorphoSys AG And Galapagos NV (GLPG.BR) Advance Joint Antibody Program In Inflammatory Diseases Into Preclinical Development 7/23/2014
China Cord Blood Corporation And Cordlife Group Limited Announce Collaboration To Aid Asia-Based Patients With Cord Blood Stem Cell Therapy 7/23/2014
Iroko Pharmaceuticals Continues To Expand Commercialization Of ZORVOLEX Ex-US 7/22/2014
ICON And University of Cambridge Collaborate To Deliver Educational Programme On Pricing & Market Access Strategy 7/22/2014
Basilea Pharmaceutica (BSLN.SW) To Launch Zevtera®/Mabelio®) (ceftobiprole medocaril) In Europe Through A Commercial Services Provider 7/21/2014
Helsinn Group And Marketing Enter Into Agreement For Marketing Rights Of Netupitant-Palonosetron Fixed-Dose Combination (NEPA) In The UK And Ireland And For Palonosetron Monotherapy In The UK 7/17/2014
The Medicines Patent Pool Signs A Record Seven New Sub-Licences To Speed The Availability Of Generic HIV Medicines To Developing Countries 7/17/2014
Eli Lilly and Company (LLY) Inks $45 Million Immunotherapy Development Deal With Immunocore Limited 7/16/2014
Harlan Laboratories, Inc. And Fluofarma Sign Strategic Collaboration Agreement 7/15/2014
Novartis AG (NVS) To Test Alzheimer's Drugs In Patients Without Symptoms 7/15/2014
LEO Pharma & Klox Technologies Strike Global Dermatology Deal 7/15/2014
Hovione And Merrion Pharmaceuticals, Inc. Announce Strategic Partnership On Use Of Merrion's GIPET Technology 7/15/2014
Geisinger Health System And Indivumed Inc. Partner For Personalized Medicine Initiative 7/15/2014
Novartis AG (NVS), Google Inc. Strike Smart Contact Lenses Pact 7/15/2014
EU Nations Join Forces Against Gilead Sciences, Inc. (GILD)'s "Exorbitant" Hepatitis C Drug 7/14/2014
Genmab A/S (GEN.CO) To Receive Milestone Payment In Duobody Platform Collaboration With Janssen Biotech Inc. (JNJ) 7/14/2014
Hemispherx Biopharma (HEB) And Bioclones, A Leading South African Biotechnology Company, Join Forces On Novel Therapeutic Cancer Vaccine 7/14/2014
NicOx SA (COX.PA) Focuses U S. Operations On National Launches Of Sjo™ And Retnagene™ And Restructures RPS® Licensing Agreement 7/10/2014
HD Biosciences Co., Ltd And Marshall University School of Medicine Reach Drug Discovery Co-Development Agreement 7/10/2014
Collaboration Between Glatt And Innopharma Labs For Real-Time In-Line Particle Characterisation In Batch / Continuous Production 7/10/2014
Lightlake Therapeutics Inc. (LLTP) Signs Agreement With Commercial Contract Manufacturer For Its Opioid Overdose Reversal Treatment 7/9/2014
AstraZeneca PLC (AZN), Max Planck Institute To Create Satellite Chemistry Unit 7/9/2014
uniQure And Medison Pharma Ltd. Sign Glybera® Distribution Agreement For Israel 7/9/2014
Protea Biosciences, Inc. And Insphero AG Enter Into Collaboration And Co-Marketing Agreement To Combine 3D Technologies 7/9/2014
Evotec AG (EVTG.F) To Collaborate With Fraunhofer In Joint Drug Discovery Programmes 7/8/2014
PHT Corporation Selects Google Inc. Nexus Android Smartphone For Logpad® System Use In Clinical Research Programs 7/8/2014
Incyte Corporation (INCY) Grabs $25 Million Milestone From Novartis AG (NVS) 7/8/2014
Compugen Ltd. (CGEN) Discloses Achievement Of Milestone In Cancer Immunotherapy Collaboration With Bayer HealthCare (BAY) 7/7/2014
Yabao Pharmaceuticals Enters Innovative Partnership With Eli Lilly and Company (LLY) To Develop Diabetes Treatment 7/7/2014
Cliniworks Forms A Strategic Alliance With Pfizer Inc. (PFE) To Develop A Population Health Management Platform With Advanced Analytics And Patient Care Capabilities 7/7/2014
Genmab A/S (GEN.CO) Reaches USD 25 Million Milestone In Daratumumab Collaboration With Janssen Biotech Inc. (JNJ) 7/7/2014
Sanofi (France) (SAN.PA) Raises Stake In Regeneron Pharmaceuticals, Inc. (REGN) 7/3/2014
UCB Group (UCBJF.PK) And Dermira Enter Into Strategic Collaboration In Dermatology To Broaden Patient Access To Cimzia® (Certolizumab Pegol) 7/3/2014
Biohit And Giraffes Pharmaceuticals Co. To Sign An Acetium Distribution Agreement 7/1/2014
First Licensing Deals For Stem Cell Company Accellta 7/1/2014
CureVac GmbH, Sanofi (France) (SAN.PA) Strike €150.5 Million+ Vaccine Pact 7/1/2014
Helsinn Group And Gen Ilac Establish A Collaboration For Anamorelin In Turkey 6/30/2014
VirtualScopics, LLC Signs An Alliance Framework Agreement With IXICO Plc; Commercial And Operational Alliance To Provide Clinical Trials Industry With Global Capabilities And A Full Range Of Therapeutic Areas And Modality Expertise 6/27/2014
Debiopharm And Nobelex Biotech Start Two Collaborations On Development Of New Antibiotics Against N. Gonorrhoeae And Enteric Species 6/26/2014
Marcomm Systems Group And Corcanna Group Strike Strategic Partnership Deal To Aid Medical Marijuana Producers 6/25/2014
Cambridge-Based Mersana Therapeutics, Inc. Strikes New Oncology Pact Worth $792 Million With Merck KGaA (MKGAF.PK) 6/25/2014
Bionomics Limited (BNO.AX) Clinches Alzheimer's Research And Funding Deal With Merck & Co., Inc. (MRK) Worth Up To $526 Million 6/24/2014
Agreement On Phase 3 Trial Protocol Of OSE Pharma's OSE-2101 From The FDA And European Medicines Agency 6/24/2014
Cook Pharmica LLC And Selexis SA Establish Customized Biologic Drug Development And Manufacturing Services Platform 6/24/2014
Ferring Pharmaceuticals, Roche (RHHBY) Partner Up To Make Personalised Infertility Treatment Possible 6/24/2014
Aurigene Discovery Technologies Limited And Orion Corporation Announce Research, Collaboration And Option Agreement For Rights To Aurigene's Epigenetics Program For Pan BET And Selective BET Bromodomain Inhibitors 6/24/2014
Sanofi (France) (SAN.PA) Throws Cancer Drug Back To Merrimack Pharmaceuticals Inc. (MACK) 6/23/2014
Servier And miRagen Therapeutics Extend Collaboration For The Research, Development And Commercialization Of Microrna-Targeting Drugs For Cardiovascular Disease 6/23/2014
China Biologic Products Announces Favorable Reduction In Value Added Tax Rate 6/23/2014
Major Drugmakers Like AstraZeneca PLC (AZN), GlaxoSmithKline (GSK). And Johnson & Johnson (JNJ) Link Up With Academia In Huge $27 Million UK Dementia Project 6/20/2014
Endocyte, Inc. (ECYT) Plummets After Merck & Co., Inc. (MRK) Backs Out Of Drug Development Deal; Stock Down -13.99% At Market Close (June 18, 2014) 6/19/2014
French Biotech Cellectis (ALCLS) Surges As Pfizer Inc. (PFE) Signs Cancer Immunotherapy Pact Worth $265 Million 6/19/2014
NicOx SA (COX.PA) And Sequenom Inc. (SQNM) Announce The Launch Of Expanded Access To Retnagene™ Test Portfolio In The U.S. 6/19/2014
Evotec AG (EVTG.F) Receives Milestone Payment As Part Of Its Discovery Alliance With Boehringer Ingelheim Corporation 6/19/2014
CEA-Leti And Akrivis Technologies To Develop Nanomedicine Platform For High Payload Targeted Drug Delivery 6/19/2014
3SBio Inc. (SSRX) Exclusively Licenses Pegsiticase (Uricase PEG-20) To Selecta Biosciences, Inc. To Develop Drug Candidate To Treat Gout 6/18/2014
uniQure And Medison Pharma Ltd. Sign Glybera Distribution Agreement For Israel 6/18/2014
Merck KGaA (MKGAF.PK) Terminates Multiple Schlerosis Drug License Agreement With Ono Pharmaceutical Company, Ltd. 6/17/2014
Sanofi (France) (SAN.PA), Medtronic, Inc. (MDT) Team Up To Develop New Diabetes Devices 6/17/2014
DrugDev Announces CFS Clinical Achieves Unprecedented $1 Billion Milestone in Global Investigator Payments 6/16/2014
Biopas And moksha8 Announce Strategic Alliance To Commercialize Specialty Pharmaceuticals Across Latin America 6/16/2014
Allenex AB Release: Three New Products Will Be Launched Globally 6/13/2014
Parion Sciences Announces Exclusive Option Agreement For The Development And Commercialization Of P-321 In Ophthalmology In Certain Asian Territories 6/12/2014
MorphoSys AG And Merck Serono Enter Strategic Immuno-Oncology Collaboration 6/12/2014
GlaxoSmithKline (GSK)'s ViiV Healthcare Joins Johnson & Johnson (JNJ)'s Janssen Research & Development To Develop Single-Pill HIV Drug 6/12/2014
AstraZeneca PLC (AZN) Beefs Up Pipeline With $232 Million Synairgen plc Asthma Deal 6/12/2014
RuiYi (formerly Anaphore) And iHuman Institute Form Collaboration To Identify Novel Antibodies Targeting GPCRs 6/11/2014
Beactica Initiates Drug Discovery Collaboration With Medivir AB (MVRBF) 6/10/2014
Biochrom Ltd. And Gilson, Inc. Sign Distribution Agreement To Deliver Automated ELISAs 6/10/2014
Isis Pharmaceuticals, Inc. (ISIS) Pockets $15 Million From AstraZeneca PLC (AZN) On ISIS-ARRx Study Initiation 6/10/2014
INVISTA And EUCODIS Bioscience To Collaborate On Development Of Enzymes For The Production Of Industrial Chemicals 6/5/2014
LALREAN, A Latin American Network Of Excellence For The Study Of Liver Diseases, Enters Into A Collaboration With Advanced Biological Laboratories SA (ABL) To Enhance Regional Understanding Of The Burden Of Hepatitis C In Latin America 6/5/2014
Cegedim SA Relationship Management Partners With Scribe Software To Enable Platform Connectivity 6/5/2014
Shuwen Biotech And DiagnoCure (CUR) Sign Exclusive License And Collaboration Agreement For Commercializing Previstage™ GCC Colorectal Cancer Staging Test In China 6/5/2014
Genmab A/S (GEN.CO) Announces Duobody And Hexabody Platform Collaboration With Undisclosed Biotechnology Company 6/4/2014
GW Pharmaceuticals Announces Agreement With New York State To Investigate Use Of CBD To Treat Medication-Resistant Epilepsies In Children 6/4/2014
arGEN-X Inks Long-Term Alliance With Shire Pharmaceuticals (SHPG) Worth $20.4 Million 6/4/2014
Foamix Announces Collaboration With National Institutes of Health (NIH) 6/3/2014
Cambridge Research Biochemicals And Key Organics Announce An Exclusive Global Supply & Marketing Agreement For Peptides 6/3/2014
Beijing Institute of Genomics And Zixin Pharmaceutical Industrial Announce China-Developed Genomics Sequencer 6/3/2014
Bayer AG (BAYZF) Pays $68 Million Upfront For Orion Corporation's Prostate Cancer Candidate ODM-201 6/2/2014
Advanced Biological Laboratories SA (ABL) And RDI Collaborate To Enhance HIV Patient Management 6/2/2014
EBD Group And Current Partnering Form Strategic Collaboration 6/2/2014
Adaptimmune Ltd., GlaxoSmithKline (GSK) Strike $350 Million Cancer Immunotherapy Pact 6/2/2014
QIAGEN N.V. (QGEN) And Eli Lilly and Company (LLY) Collaborate To Co-Develop Companion Diagnostics For Simultaneous Analysis Of Dna And Rna Biomarkers In Common Cancers 5/30/2014
NicOx SA (COX.PA): Santen, Inc. Grants EuPharmed Extension Of Exclusive Rights To Distribute Cationorm® In Italy 5/30/2014
Dako A/S (Acquired by Agilent Technologies, Inc.) (A) And U.S.-Based Merck & Co., Inc. (MRK) To Collaborate On Companion Diagnostic Test For Analysis Of Tumor PD-L1 Levels 5/30/2014
uniQure And Medison Pharma Ltd. Sign Glybera® Distribution Agreement For Israel 5/29/2014
Novozymes Biopharma Enters Agreement With A Leading Vaccine Company To Conduct Research On A Novel Subunit Vaccine Complex Based On Albumin Fusion Technology 5/29/2014
NicOx SA (COX.PA): Santen Grants Eupharmed Extension Of Exclusive Rights To Distribute Cationorm® In Italy 5/28/2014
Celerion And Korean Drug Development Fund Form Collaboration To Strengthen Early Phase Clinical Research In South Korea 5/28/2014
EffRx Signs Binosto® Distribution Agreements In Russia And Africa 5/28/2014
MacroGenics, Inc. (MGNX) And Takeda Pharmaceutical Co. Ltd. (TKPYY) Enter Strategic Alliance To Develop DART For Treatment Of Autoimmune Disorders 5/27/2014
Orient Europharma Co., Ltd. And Debiopharm Announce Their Partnership And The Launch Of Pamorelin®LA In Singapore 5/27/2014
Targos Molecular Pathology GmbH And WuXi PharmaTech Co., Ltd. To Collaborate In Clinical Biomarker Services And Pathology Training In China 5/23/2014
Wilex AG (WL6.DE) Sends Back Some Promising Drugs To UCB, Inc. (UCBJF.PK) In Effort To Stay Alive 5/22/2014
Cambridge Research Biochemicals Renews Supply Contract With The Medical Research Council For A Fourth Year 5/20/2014
Orexo AB (ORXOF) Announces New Partner For The Commercialization Of Zubsolv® In The United States 5/20/2014
Ophthotech Corporation (OPHT) May Pocket $1 Billion From Eye Drug Deal With Novartis AG (NVS), Ophthotech Stock Up +24.48% At Market Close (May 20, 2014) 5/20/2014
Takeda Pharmaceutical Co. Ltd. (TKPYY) Partners With Wipro To Enable A Global “As-A-Service” IT Platform 5/19/2014
Ardelyx Inc. Receives $25 Million Milestone From AstraZeneca PLC (AZN) For Commencement Of Phase 2b Clinical Trial Of Tenapanor 5/15/2014
NeoStem, Inc. Out-Licenses China Rights For Cancer Immunotherapy To Cellular Biomedicine Group 5/14/2014
ENTERTECH SYSTEMS And Paxton Deliver Next-Generation Biometric Access Control To The UK With Suprema Technology 5/14/2014
MRC Technology And Daiichi Sankyo, Inc. (4568.t) Collaborate To Identify Novel Targets For Drug Discovery 5/14/2014
DBV Technologies Announces Clinical Trial Agreement To Develop A Treatment For Milk-Induced Eosinophilic Esophagitis In Children 5/13/2014



//-->